225 results on '"Ancel, P.-Y."'
Search Results
2. Propositions sur la prise en charge en cas d’extrême prématurité – Le groupe de travail « Extrême Prématurité » pour la SFMP, le CNGOF et la SFN
3. Palivizumab administration in preterm infants in France: EPIPAGE-2 cohort study
4. The interrelatedness of cognitive abilities in very preterm and full‐term born children at 5.5 years of age: a psychometric network analysis approach
5. Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) — Texte des recommandations (texte court)
6. Protection cérébrale de l’enfant né prématuré par le sulfate de magnésium
7. Impact of clinical and/or histological chorioamnionitis on neurodevelopmental outcomes in preterm infants: A literature review
8. The interrelatedness of cognitive abilities in very preterm and full‐term born children at 5.5 years of age: a psychometric network analysis approach.
9. Parcours et développement neurologique et comportemental de l’enfant prématuré
10. Gestational age at diagnosis of early‐onset fetal growth restriction and impact on management and survival: a population‐based cohort study
11. Inpatient mother-and-child postpartum psychiatric care: Factors associated with improvement in maternal mental health
12. Anaesthesia mode for caesarean section and mortality in very preterm infants: An epidemiologic study in the EPIPAGE cohort
13. Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study.
14. Children's mental and behavioral health, schooling, and socioeconomic characteristics during school closure in France due to COVID-19: the SAPRIS project.
15. Umbilical cord blood procalcitonin as a risk factor for mortality in very premature infants
16. Pineal cysts in children
17. Cancers du sein bilatéraux synchrones : facteurs de risque, diagnostic, histologie, traitement
18. Early growth and neurodevelopmental outcome in very preterm infants: impact of gender
19. Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age: OC01
20. Le point sur la prématurité en 2009
21. Structuration nationale pour la prise en charge des cancers en cours de grossesse : réseau CALG (cancers associés à la grossesse)
22. Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age
23. Cohort study from 11 European countries highlighted differences in the use and efficacy of hypothermia prevention strategies after very preterm birth
24. Prognostic value of diffusion‐weighted magnetic resonance imaging of brain in fetal growth restriction: results of prospective multicenter study
25. Propositions sur la prise en charge en cas d’extrême prématurité – Le groupe de travail « Extrême Prématurité » pour la SFMP, le CNGOF et la SFN
26. Difficultés de suivi d'une cohorte d'enfants nés grands prématurés : EPIPAGE Paris–Petite-Couronne
27. Height at 2 and 5 years of age in children born very preterm: the EPIPAGE study
28. Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients
29. Neurodevelopment of children born very preterm and free of severe disabilities: the Nord-Pas de Calais Epipage cohort study
30. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study
31. Wide variation in severe neonatal morbidity among very preterm infants in European regions
32. Wide variation in severe neonatal morbidity among very preterm infants in european regions
33. Early extubation is not associated with severe intraventricular hemorrhage in preterm infants born before 29 weeks of gestation. Results of an EPIPAGE-2 cohort study
34. Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts
35. Handicap neuro-sensoriel grave de l’enfant grand prématuré: Aspects épidémiologiques
36. Strategies for assessing the impact of loss to follow-up on estimates of neurodevelopmental impairment in a very preterm cohort at 2 years of age.
37. Les troubles du sommeil à 1 an et les facteurs précoces associés chez les enfants nés prématurés de la cohorte EPIPAGE-2
38. Cohort study from 11 European countries highlighted differences in the use and efficacy of hypothermia prevention strategies after very preterm birth
39. Epipage 2 : une étude épidémiologique nationale pour mieux connaître la prise en charge et le devenir des enfants grands prématurés
40. Evidence-based neonatal unit practices and determinants of postnatal corticosteroid-use in preterm births below 30 weeks ga in europe. A population-based cohort study
41. Use of magnesium sulfate before 32 weeks of gestation : A European population-based cohort study
42. Neurodevelopment at 2 years and umbilical artery Doppler in cases of very preterm birth after prenatal hypertensive disorder or suspected fetal growth restriction: EPIPAGE-2 prospective population-based cohort study.
43. Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study.
44. Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study
45. Use of magnesium sulfate before 32 weeks of gestation: A European population-based cohort study
46. Evidence-based neonatal unit practices and determinants of Postnatal corticosteroid-use in preterm births below 30 weeks ga in Europe: A population-based cohort study
47. Use of magnesium sulfate before 32 weeks of gestation:A European population-based cohort study
48. Épidémiologie et facteurs de risque de la prématurité
49. Protection cérébrale de l’enfant né prématuré par le sulfate de magnésium
50. Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) — Texte des recommandations (texte court)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.